- 37 次围观
产品图片
货号/SKU
NR-2562
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-2562??Yersinia pestis, F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli(Proteins)|Yersinia pestis|F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli|-70°C or colder|NIAID/NIHAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Yersinia pestis F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli, NR-2562."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
This product is also available as BEI Resources NR-2561. Please note that each vial of NR-2561 contains approximately 1.5 mg of F1-V fusion protein, while each vial of NR-2562 contains approximately 0.6 mg of F1-V fusion protein.
Recombinant Yersinia pestis (Y. pestis) F1-V fusion protein, monomer-enriched antigen was purified from Escherichia coli and depleted of DNA and endotoxin. Originally developed by the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID), F1-V is a fusion protein consisting of the Fraction 1 (F1) capsular protein and the virulence-associated (V) regulatory protein from Y. pestis (GenPept: AAY23169). NR-2562 was demonstrated to be functionally active based on its reactivity with antibodies to both the F1 and V proteins. NR-2562 is protective in a Y. pestis lethal challenge murine model.
Each vial of NR-2562 contains lyophilized (approximately 0.6 mg in 20 mM L-arginine, 10 mM sodium chloride, 1 mM L-cysteine, and 2% w/v D-mannitol) recombinant F1-V fusion protein. NR-2562 should be reconstituted with 0.5 mL of sterile water.
This product is also available as BEI Resources NR-2561. Please note that each vial of NR-2561 contains approximately 1.5 mg of F1-V fusion protein, while each vial of NR-2562 contains approximately 0.6 mg of F1-V fusion protein.
Recombinant Yersinia pestis (Y. pestis) F1-V fusion protein, monomer-enriched antigen was purified from Escherichia coli and depleted of DNA and endotoxin. Originally developed by the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID), F1-V is a fusion protein consisting of the Fraction 1 (F1) capsular protein and the virulence-associated (V) regulatory protein from Y. pestis (GenPept: AAY23169). NR-2562 was demonstrated to be functionally active based on its reactivity with antibodies to both the F1 and V proteins. NR-2562 is protective in a Y. pestis lethal challenge murine model.
Each vial of NR-2562 contains lyophilized (approximately 0.6 mg in 20 mM L-arginine, 10 mM sodium chloride, 1 mM L-cysteine, and 2% w/v D-mannitol) recombinant F1-V fusion protein. NR-2562 should be reconstituted with 0.5 mL of sterile water.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送到NIAID进行批准. 此产品也可作为Bei Resources NR-2561提供.请注意,NR-2561的每个小瓶含有约1.5mg F1-V融合蛋白,而NR-2562的每个小瓶含有约0.6mg F1-V融合蛋白. 重组 yersinia pestis(Y. pestis) F1-V融合蛋白,从大肠杆菌纯化单体富集的抗原并耗尽DNA和内毒素.最初由美国军队医学研究所传染病(USAMRIID),F1-V是一种由馏分1(F1)荚膜蛋白和来自 Y的毒力相关(V)调节蛋白组成的融合蛋白. Pestis (Genpept:Aay23169). NR-2562基于其与F1和V蛋白的抗体的反应性证明在功能上活性. NR-2562在 Y中是保护性的. Pestis 致死的挑战鼠模型. 含冻干(约0.6mg,在20 mm l-精氨酸,10mM氯化钠,1mm l-半胱氨酸和2%w / v d-甘露醇)重组F1-V融合蛋白. NR-2562应用0.5毫升无菌水重构.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2021-12-21
2021-12-02
2024-06-22
2022-03-31
2022-04-01
2023-11-14
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2023-10-21
2021-12-21
2022-06-17
2022-04-01
2024-08-16